<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>国广有话说 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-27T20:20:05+08:00</updated>
  <subtitle>立足于客观公正，挖掘发现医药企业价值投资机会</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>恒瑞医药怒涨30%，对国内创新药意味着什么？【东吴医药朱国广团队|1227周报】</title>
    <updated>2020-12-27T17:28:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/OOlBLn07u9v1jFpSjKcHvA</id>
    <link href="https://mp.weixin.qq.com/s/OOlBLn07u9v1jFpSjKcHvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！21年医药策略：医药浪潮之巅后的新选择，估值OR信仰？【东吴医药朱国广团队】（word版近100页）</title>
    <updated>2020-12-23T22:49:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/fJ4CcKNkwMmvcvNwwfoYMA</id>
    <link href="https://mp.weixin.qq.com/s/fJ4CcKNkwMmvcvNwwfoYMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药的出路在哪里？全球专利体系！【东吴医药朱国广团队|1220周报】</title>
    <updated>2020-12-20T17:20:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/hllwGCDdeQQp60-_WyA5Dg</id>
    <link href="https://mp.weixin.qq.com/s/hllwGCDdeQQp60-_WyA5Dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药企稳后，2021年战略性配置高端制造！【东吴医药朱国广团队|1213周报】</title>
    <updated>2020-12-13T12:29:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/GHUF4vJteZd7SJpsdO2-_g</id>
    <link href="https://mp.weixin.qq.com/s/GHUF4vJteZd7SJpsdO2-_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>万泰生物（603392）：止于至善的基因工程技术领跑者【东吴医药朱国广团队】</title>
    <updated>2020-12-07T18:16:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/MjjeiAwvIcrBLsQUyKkpjw</id>
    <link href="https://mp.weixin.qq.com/s/MjjeiAwvIcrBLsQUyKkpjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年为何战略性重视医药的“芯片”原料药资产？【东吴医药朱国广团队|1204周报】</title>
    <updated>2020-12-06T15:11:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/t3wiugd2s_VUqBMItxHlSQ</id>
    <link href="https://mp.weixin.qq.com/s/t3wiugd2s_VUqBMItxHlSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>器械集采扩面，哪类公司方能最终胜出？【东吴医药朱国广团队|1127周报】</title>
    <updated>2020-11-29T16:31:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/gA2oumAxCXf_IaDgU_DxIw</id>
    <link href="https://mp.weixin.qq.com/s/gA2oumAxCXf_IaDgU_DxIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“横看成岭侧成峰”——“秒懂”全球创新药系列研究之靶点掘金（第04期：CDK4/6）【东吴医药朱国广团队】</title>
    <updated>2020-11-26T19:59:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/RMrHhTP0tAKb_8mZvRW02g</id>
    <link href="https://mp.weixin.qq.com/s/RMrHhTP0tAKb_8mZvRW02g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最强医药股的补跌说明什么？【东吴医药朱国广团队|1122周报】</title>
    <updated>2020-11-22T15:58:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/-0mIZ6_J9iSjLJHYgRUX6g</id>
    <link href="https://mp.weixin.qq.com/s/-0mIZ6_J9iSjLJHYgRUX6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药行业动态追踪系列研究之2020医保谈判猜想（第01期：政策点拨）【东吴医药朱国广团队】</title>
    <updated>2020-11-18T14:27:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/Y7oTnYR53A4Qdmk0cvchIw</id>
    <link href="https://mp.weixin.qq.com/s/Y7oTnYR53A4Qdmk0cvchIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>